In-cell bioluminescence resonance energy transfer (BRET)-based assay uncovers ceritinib and CA-074 as SARS-CoV-2 papain-like protease inhibitors.
第一作者:
Mei,Li
第一单位:
Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.;State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
作者:
主题词
人类(Humans);砜类(Sulfones);嘧啶类(Pyrimidines);抗病毒药(Antiviral Agents);蛋白酶抑制药(Protease Inhibitors);分子结构(Molecular Structure);剂量效应关系, 药物(Dose-Response Relationship, Drug);构效关系(Structure-Activity Relationship)
DOI
10.1080/14756366.2024.2387417
PMID
39163165
发布时间
2024-08-23
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文